Un-explained Visual Loss Following Silicone Oil Removal: Results of the Pan American Collaborative Retina Study (PACORES) Group
Overview
Authors
Affiliations
Purpose: To report the incidence and clinical features of patients that experienced un-explained visual loss following silicone oil (SO) removal.
Methods: Multicenter retrospective study of patients that underwent SO removal during 2000-2012. Visual loss of ≥2 lines was considered significant.
Results: A total of 324 eyes of 324 patients underwent SO removal during the study period. Forty two (13%) eyes suffered a significant visual loss following SO removal. Twenty three (7.1%) of these eyes lost vision secondary to known causes. In the remaining 19 (5.9%) eyes, the loss of vision was not explained by any other pathology. Eleven of these 19 patients (57.9%) were male. The mean age of this group was 49.2 ± 16.4 years. Eyes that had an un-explained visual loss had a mean IOP while the eye was filled with SO of 19.6 ± 6.9 mm Hg. The length of time that the eye was filled with SO was 14.8 ± 4.4 months. In comparison, eyes that did not experience visual loss had a mean IOP of 14 ± 7.3 mm Hg ( < 0.0002) and a mean tamponade duration of 9.3 ± 10.9 months ( < 0.0001).
Conclusions: An un-explained visual loss after SO removal was observed in 5.9% of eyes. Factors associated with this phenomenon included a higher IOP and longer SO tamponade duration.
An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy.
Hammer M, Ie A, Eibenberger K, Auffarth G, Xue K BMC Ophthalmol. 2025; 25(1):38.
PMID: 39844136 PMC: 11756122. DOI: 10.1186/s12886-024-03834-7.
Ophthalmic Outcomes After Silicone Oil Removal.
Jiao G, Shah P, Shakin E, Lee J, Ferrone P, Rhee D J Vitreoretin Dis. 2024; :24741264241271645.
PMID: 39554621 PMC: 11561951. DOI: 10.1177/24741264241271645.
Jester D, Smith J Am J Ophthalmol Case Rep. 2024; 36:102023.
PMID: 39175931 PMC: 11338951. DOI: 10.1016/j.ajoc.2024.102023.
Vitreous substitutes and tamponades - A review of types, applications, and future directions.
Shettigar M, Dave V, Chou H, Fung A, Iguban E, March de Ribot F Indian J Ophthalmol. 2024; 72(8):1102-1111.
PMID: 39078953 PMC: 11451774. DOI: 10.4103/IJO.IJO_2417_23.
Vision loss associated with silicone oil endotamponade in vitreoretinal surgery - a review.
Januschowski K, Rickmann A, Smith J, Pastor-Idoate S, Pastor J Graefes Arch Clin Exp Ophthalmol. 2024; 262(11):3453-3463.
PMID: 38888804 DOI: 10.1007/s00417-024-06520-y.